Irisin alleviates pulmonary epithelial barrier dysfunction in sepsis-induced acute lung injury via activation of AMPK/SIRT1 pathways
Authors:
Open Access
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 118, 109363
Abstract
No abstract availableKeywords
Funding Information
- Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund (znpy2018020)
This publication has 28 references indexed in Scilit:
- Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathwayInternational Journal of Obesity, 2015
- Isoflurane Ameliorates Acute Lung Injury by Preserving Epithelial Tight Junction IntegrityAnesthesiology, 2015
- Stimulation of Brain AMP-Activated Protein Kinase Attenuates Inflammation and Acute Lung Injury in SepsisMolecular Medicine, 2015
- Fish-oil emulsion (omega-3 polyunsaturated fatty acids) attenuates acute lung injury induced by intestinal ischemia–reperfusion through Adenosine 5′-monophosphate-activated protein kinase–sirtuin1 pathwayJournal of Surgical Research, 2014
- Treadmill Training Increases SIRT-1 and PGC-1αProtein Levels and AMPK Phosphorylation in Quadriceps of Middle-Aged Rats in an Intensity-Dependent MannerMediators of Inflammation, 2014
- Resveratrol reduces acute lung injury in a LPS-induced sepsis mouse model via activation of Sirt1Molecular Medicine Reports, 2013
- Inhibition of AMP-Activated Protein Kinase Accentuates Lipopolysaccharide-Induced Lung Endothelial Barrier Dysfunction and Lung Injury in VivoThe American Journal of Pathology, 2013
- Irisin, Light My FireScience, 2012
- Exercise hormone fights metabolic diseaseNature Reviews Drug Discovery, 2012
- Repression of P66Shc Expression by SIRT1 Contributes to the Prevention of Hyperglycemia-Induced Endothelial DysfunctionCirculation Research, 2011